Jacqueline Suk Danik, Dr.P.H., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Atria | 1 | 2022 | 1321 | 0.530 |
Why?
|
| Lipoprotein(a) | 3 | 2013 | 484 | 0.510 |
Why?
|
| Overweight | 3 | 2023 | 2389 | 0.490 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 96 | 0.420 |
Why?
|
| C-Reactive Protein | 7 | 2009 | 3752 | 0.400 |
Why?
|
| Fluorobenzenes | 1 | 2013 | 180 | 0.380 |
Why?
|
| Thromboembolism | 1 | 2016 | 1003 | 0.350 |
Why?
|
| Muscular Diseases | 1 | 2013 | 539 | 0.320 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 5052 | 0.310 |
Why?
|
| Cholecalciferol | 3 | 2023 | 538 | 0.310 |
Why?
|
| Fibrinogen | 1 | 2009 | 866 | 0.260 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2023 | 1367 | 0.250 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 4276 | 0.250 |
Why?
|
| Anticoagulants | 2 | 2019 | 4730 | 0.240 |
Why?
|
| Hemorrhage | 1 | 2016 | 3521 | 0.240 |
Why?
|
| Vitamins | 4 | 2023 | 1611 | 0.240 |
Why?
|
| Connexin 43 | 1 | 2004 | 201 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2013 | 15386 | 0.220 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3118 | 0.220 |
Why?
|
| Sulfonamides | 1 | 2013 | 1955 | 0.220 |
Why?
|
| Gap Junctions | 1 | 2004 | 229 | 0.220 |
Why?
|
| Stroke | 4 | 2023 | 9693 | 0.220 |
Why?
|
| Dietary Supplements | 6 | 2023 | 3325 | 0.220 |
Why?
|
| Aortic Valve | 2 | 2023 | 1972 | 0.200 |
Why?
|
| Cardiovascular Diseases | 7 | 2023 | 15319 | 0.200 |
Why?
|
| Pyrimidines | 1 | 2013 | 2960 | 0.180 |
Why?
|
| Psoriasis | 1 | 2009 | 909 | 0.180 |
Why?
|
| Women's Health | 2 | 2009 | 2037 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 1770 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 2 | 2023 | 2038 | 0.170 |
Why?
|
| DNA | 1 | 2013 | 7208 | 0.160 |
Why?
|
| Crohn Disease | 2 | 2009 | 2244 | 0.160 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 131 | 0.160 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2021 | 603 | 0.140 |
Why?
|
| Calcium | 2 | 2023 | 5656 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 1611 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2004 | 1285 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2019 | 289 | 0.130 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 1034 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 2142 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2021 | 892 | 0.120 |
Why?
|
| Vitamin D | 4 | 2023 | 3240 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2023 | 1403 | 0.110 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1209 | 0.100 |
Why?
|
| Body Composition | 1 | 2021 | 2384 | 0.100 |
Why?
|
| Genetic Variation | 3 | 2007 | 6454 | 0.100 |
Why?
|
| Double-Blind Method | 4 | 2023 | 12227 | 0.100 |
Why?
|
| Warfarin | 1 | 2019 | 1480 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2023 | 5142 | 0.090 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11658 | 0.090 |
Why?
|
| Genotype | 4 | 2013 | 12788 | 0.090 |
Why?
|
| Adiposity | 2 | 2021 | 1825 | 0.090 |
Why?
|
| Inflammation | 2 | 2009 | 10633 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 10096 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12217 | 0.090 |
Why?
|
| Echocardiography | 1 | 2022 | 4911 | 0.080 |
Why?
|
| Obesity | 5 | 2023 | 12728 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3272 | 0.080 |
Why?
|
| Sex Factors | 3 | 2023 | 10284 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2015 | 950 | 0.080 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 834 | 0.070 |
Why?
|
| Humans | 29 | 2023 | 746630 | 0.070 |
Why?
|
| Tyrosine | 1 | 2001 | 1441 | 0.070 |
Why?
|
| Angina, Unstable | 1 | 2001 | 917 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2023 | 53253 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2013 | 3534 | 0.070 |
Why?
|
| Alleles | 2 | 2013 | 6837 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15010 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2006 | 3421 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2013 | 1168 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2010 | 942 | 0.060 |
Why?
|
| Inbreeding | 1 | 2004 | 48 | 0.060 |
Why?
|
| Tropomyosin | 1 | 1995 | 98 | 0.060 |
Why?
|
| Endocardium | 1 | 2006 | 250 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 368 | 0.060 |
Why?
|
| Female | 19 | 2023 | 382450 | 0.060 |
Why?
|
| Aged | 9 | 2023 | 164383 | 0.060 |
Why?
|
| Phenotype | 3 | 2013 | 16261 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3033 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2007 | 1251 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 748 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2004 | 440 | 0.050 |
Why?
|
| Risk Factors | 8 | 2023 | 72447 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 1761 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 38771 | 0.050 |
Why?
|
| Troponin | 1 | 1995 | 513 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2023 | 6319 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2688 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2023 | 40534 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2009 | 2556 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2013 | 17445 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 1502 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12021 | 0.040 |
Why?
|
| Male | 13 | 2023 | 351420 | 0.040 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1001 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2010 | 1488 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 763 | 0.040 |
Why?
|
| Middle Aged | 11 | 2023 | 214618 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3161 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 6782 | 0.040 |
Why?
|
| Longevity | 1 | 2004 | 1031 | 0.040 |
Why?
|
| Apoprotein(a) | 1 | 2006 | 17 | 0.040 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2006 | 90 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2006 | 89 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 1529 | 0.030 |
Why?
|
| Thrombosis | 1 | 2010 | 2998 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1995 | 1245 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 1782 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2020 | 899 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4343 | 0.030 |
Why?
|
| Thymine | 1 | 2005 | 69 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2616 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 433 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 20820 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2023 | 1458 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3842 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2006 | 318 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2006 | 3025 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2007 | 2333 | 0.030 |
Why?
|
| Cytosine | 1 | 2005 | 211 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 8305 | 0.030 |
Why?
|
| Guanine | 1 | 2005 | 275 | 0.030 |
Why?
|
| United States | 3 | 2021 | 70437 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2023 | 2563 | 0.030 |
Why?
|
| Introns | 1 | 2005 | 968 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1689 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 3978 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1356 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3706 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 39622 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 12657 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6463 | 0.020 |
Why?
|
| Haplotypes | 1 | 2006 | 2722 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4189 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 1573 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14253 | 0.020 |
Why?
|
| Adenine | 1 | 2005 | 976 | 0.020 |
Why?
|
| Exons | 1 | 2005 | 2388 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10750 | 0.020 |
Why?
|
| Bone Density | 1 | 2021 | 3511 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 954 | 0.020 |
Why?
|
| Age Factors | 1 | 2004 | 18157 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6457 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21693 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2023 | 23464 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 2375 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 11865 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13317 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 7124 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 15555 | 0.020 |
Why?
|
| Syndrome | 1 | 2001 | 3249 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 575 | 0.020 |
Why?
|
| Lod Score | 1 | 1995 | 597 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4606 | 0.010 |
Why?
|
| Causality | 1 | 2010 | 1232 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 11966 | 0.010 |
Why?
|
| Myosins | 1 | 1995 | 402 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2023 | 78313 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2001 | 2072 | 0.010 |
Why?
|
| Mutation | 1 | 1995 | 29627 | 0.010 |
Why?
|
| Troponin T | 1 | 1995 | 751 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1995 | 2366 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13810 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29079 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 80251 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6226 | 0.010 |
Why?
|
| Genome, Human | 1 | 2008 | 4358 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9455 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6734 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 10138 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 166558 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 3032 | 0.010 |
Why?
|
| Neoplasms | 1 | 2021 | 21715 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 215192 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23154 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 86278 | 0.000 |
Why?
|